Having trouble viewing this email? View in your browser.
ESCMID Logo

9 July 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

ESCMID Study Group Research Grants: the call will close soon!

ESCMID Study Groups are the core of our Society. Through them, ESCMID actively enriches the scientific community with new findings, which results in scientific publications, including medical guidelines and textbooks. Also for 2019, ESCMID will support Study Group research projects in the fields of clinical microbiology and infectious diseases. The call to apply for the ESCMID Study Group Research Grants officially opened 17 May 2019 and the deadline for submitting your applications is 17 July 2019, 17:00 CEST.

All information regarding ESCMID Study Group Research funding is available here.

Please carefully read the updated “What you need to apply” section: important changes have been made compared to the previous call.

› Read more

ESCMID Executive Committee Election 2019: call for nominations

Dear ESCMID Member,

At the end of 2019 elections will be held among the membership to fill three (out of eight) positions in the ESCMID Executive Committee, two representing clinical microbiology and one infectious diseases. In April 2020 Past-President and Publications Officer Mario Poljak (clinical microbiology position) and Guidelines Officer Evelina Tacconelli (infectious diseases position) will complete their terms on the ESCMID Executive Committee, while ESCMID Treasurer Alexander W. Friedrich will stand for re-election for one clinical microbiology position after completing his first term.

The Nomination Subcommittee would like to encourage you to propose three candidates (two clinical microbiology specialists and one infectious diseases specialist), taking into consideration their professional excellence, leadership and communication skills, and contributions to the activities of ESCMID. Importantly, candidates must have been ESCMID members in good standing for at least the past three years. The term of office will start at the next Assembly of Members (20 April 2020) and will last four years. Candidates nominated in writing by 50 or more members from at least five different countries (with a minimum of five persons per country) will automatically be selected by the Nomination Subcommittee and their names will appear on the ballot. The Nomination Subcommittee may suggest additional candidates to ensure the balance of gender, region and field of activity.

Since no more than one ESCMID Executive Committee member may come from the same country, nominations for candidates from countries of already confirmed ESCMID Executive Committee members cannot be accepted for the next term. These countries are: Italy, Spain, Turkey, France and Switzerland. Additionally, nominees who fail to be elected may not be nominated again for the term immediately following the unsuccessful candidacy.

To nominate a candidates please complete this form and submit it until the deadline 31 August 2019
We are looking forward to your nominations.

Best regards,
Mario Poljak
Chair of the ESCMID Nomination Subcommittee

› Read more

Second ESCMID Course on Precision Medicine (26 – 28 September 2019, Rome, Italy): register now!

Don`t miss your chance to register for the Second ESCMID Course on Precision Medicine!

Upon completion of this course, participants will be able to:  

  • Understand the pharmacokinetic and epidemiologic heterogeneity in patient populations traditionally excluded from clinical studies such as the critically ill; the elderly; those with renal insufficiency; the obese; and female patients.
  • Understand the evidence (or lack thereof) for medical decision-making in these populations.
  • Explore both the limits and the strengths of current “one-size-fits-all” guidelines.
  • Understand the clinical implications of variations in local epidemiology, microbiota, and regional perceptions regarding antimicrobial use.
  • Explore the clinical evidence for recommended durations of antimicrobial therapy.
  • Understand the variation in pharmacokinetics across populations
  • Explore the ethical dilemmas in antimicrobial decision-making (the individual versus society).  

Please click here to complete your registration!

› Read more
 

2019 ESCMID Summer School wraps up in Liverpool

The 18th ESCMID Summer School concluded in Liverpool, United Kingdom following a full week of lectures, participant presentations and workshops. 79 participants from over 25 countries as far away as Australasis gathered to learn from an expert faculty of European experts, and from each other, across a variety of CM and ID areas, as well as creating friendships and collaborative partners from Europe and beyond.

Summer School 2020 will be held in Carcavelos, Portugal, from 27 June - 4 July 2020.

› Read more
 

CMI highlight: Assessing the potential of upper respiratory tract point-of-care testing: a systematic review of the prognostic significance of upper respiratory tract microbes

H. V. Thornton investigate the relationship between upper respiratory tract microbial detection and disease prognosis, including effects of antimicrobial use using MEDLINE and Embase databases.

Microbial point-of-care testing (POCT) has potential to revolutionise clinical care. Understanding prognostic value of microbes identified from the upper respiratory tract (a convenient sampling site) is a necessary first step to understand potential for upper respiratory tract POCTs in assisting antimicrobial treatment decisions for respiratory infections (RTIs).

A selection of quantitative studies reporting microbiological and prognostic data from patients of all age groups presenting with RTI with criteria such as patients presenting to healthcare or research settings with RTI, on a specific site: upper respiratory tract swab were picked. A systematic review and meta-analysis was performed.

A quarter of potential prognostic associations have been investigated. Of these, a third were significant, suggesting considerable potential for POCT. The authors suggested that future research should investigate prognostic value of positive and negative tests, and interactions between test result, use of antimicrobials and microbial resistance.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.